OLYMY (Olympus) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OLYMY Olympus Corp OLYMY
77 GF Score
Price $10.77
GF Value $16.71
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Olympus Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OLYMY
77GF Score
Olympus Corp OLYMY
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Olympus (OLYMY) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of $10.77 is trading 35.5% below its estimated GF Value™ of $16.71. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for OLYMY:

  • Short Ratio:
  • GF Value™: $16.71 vs. price of $10.77 (35.5% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the OLYMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
77GF Score

Get the complete analysis for OLYMY

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.77
Price
$16.71
GF Value